Integral Health Asset Management LLC acquired a new position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 100,000 shares of the company’s stock, valued at approximately $4,523,000. Integral Health Asset Management LLC owned 0.13% of […]
Integral Health Asset Management LLC increased its position in Envista Holdings Co. (NYSE:NVST – Free Report) by 52.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 152,000 shares of the company’s stock after purchasing an additional 52,000 shares during the […]
Integral Health Asset Management LLC boosted its holdings in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 4.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 250,000 shares of the biopharmaceutical company’s stock after buying an additional 10,000 shares during the period. […]
Integral Health Asset Management LLC boosted its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 50.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,000 shares of the company’s stock after purchasing an additional 10,000 shares during the period. Integral […]
Integral Health Asset Management LLC purchased a new position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 152,000 shares of the medical equipment provider’s stock, valued at approximately $7,605,000. Boston Scientific accounts for […]